Clinical bottom line
Patients with Ehlers-Danlos syndrome (EDS) undergoing cardiac surgery present unique anesthetic challenges due to their connective tissue fragility, vascular abnormalities, and potential for bleeding and hemodynamic instability. Current evidence, though limited and largely case-based, suggests that meticulous perioperative planning, individualized anesthetic techniques, and multidisciplinary coordination are critical to optimizing outcomes. Cardiac-valvular and vascular EDS subtypes warrant particular caution given their association with valvular dysfunction and arterial fragility. While no large-scale trials exist, emerging case reports and expert consensus underscore the importance of gentle tissue handling, vigilant monitoring, and tailored cardiovascular support during cardiac procedures in this population (INSERM et al., 2020; Wakabayashi et al., 2020).
What the evidence shows
EDS encompasses a heterogeneous group of heritable connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. Among its subtypes, cardiac-valvular EDS is distinguished by progressive valvular disease and aortic root dilation, increasing surgical risk during cardiac interventions (INSERM et al., 2020). Vascular EDS (vEDS), although less common, is associated with arterial rupture and bleeding complications, which complicate anesthetic management (Rosa Anne et al., 2017).
Although direct evidence on anesthetic management during cardiac surgery in EDS is sparse, extrapolation from related surgical contexts and subtype-specific pathophysiology informs current practice. Wakabayashi et al. (2020) describe anesthetic management in musculocontractural EDS during scoliosis surgery, highlighting the need for careful airway management, avoidance of excessive tissue traction, and preparedness for bleeding. These principles are applicable to cardiac surgery, where vascular fragility and coagulopathy risks are heightened.
Key anesthetic considerations include:
- Vascular access and monitoring: Invasive lines should be placed cautiously to minimize vessel trauma. Ultrasound guidance is recommended to reduce complications.
- Hemodynamic management: Patients may have labile blood pressure and impaired vascular tone; goal-directed therapy with close monitoring is essential.
- Coagulation: Bleeding risk is elevated due to vessel fragility and potential platelet dysfunction. Preoperative coagulation assessment and availability of blood products are advised.
- Airway management: Tissue fragility may complicate intubation and airway manipulation; gentle technique and alternative airway devices should be considered.
- Multidisciplinary coordination: Collaboration among anesthesiologists, cardiologists, surgeons, and hematologists improves perioperative planning and risk mitigation.
Laserna et al. (2021) emphasize the importance of individualized anesthetic plans in EDS patients with autonomic dysfunction, which may coexist and influence intraoperative hemodynamics. Although their focus was not cardiac surgery, the principles of tailored anesthetic depth and vasoactive support are relevant.
Caveats and uncertainty
The evidence base for anesthetic management of EDS patients undergoing cardiac surgery is limited to case reports, small series, and expert opinion. No randomized controlled trials or large observational studies specifically address this population. The heterogeneity of EDS subtypes and variable clinical manifestations further complicate generalization.
Additionally, the rarity of cardiac-valvular and vascular EDS subtypes means that many anesthesiologists may have limited direct experience. The unpredictable nature of vascular complications and bleeding poses ongoing challenges despite careful planning.
Data on long-term outcomes and optimal perioperative protocols remain lacking. The potential impact of novel anesthetic agents or techniques in this population is unstudied. Furthermore, the interplay between EDS-related autonomic dysfunction and cardiac surgery stress responses requires further elucidation.
How this may change practice
This evidence digest highlights the need for heightened vigilance and individualized anesthetic strategies in EDS patients undergoing cardiac surgery. Practitioners should:
- Engage in thorough preoperative assessment, including subtype classification and cardiovascular evaluation.
- Employ minimally traumatic vascular access techniques and prepare for bleeding management.
- Monitor hemodynamics closely with goal-directed therapy tailored to the patient’s autonomic status.
- Coordinate multidisciplinary care involving cardiology, hematology, and surgical teams.
- Consider anesthetic agents and airway devices that minimize tissue trauma.
While awaiting more robust data, anesthesiologists should incorporate these principles into perioperative protocols to mitigate risks. Institutional guidelines may be developed to standardize care pathways for this vulnerable population.